statistiche ricercatore

Nazione	#
IT - Italia	14.692
US - Stati Uniti d'America	654
SG - Singapore	161
CN - Cina	83
SE - Svezia	71
VN - Vietnam	54
BR - Brasile	46
DE - Germania	44
IN - India	25
FI - Finlandia	24
HK - Hong Kong	23
FR - Francia	19
GB - Regno Unito	16
JP - Giappone	10
UA - Ucraina	10
ZA - Sudafrica	8
AR - Argentina	7
AT - Austria	7
CZ - Repubblica Ceca	7
IE - Irlanda	7
MA - Marocco	7
NL - Olanda	7
BD - Bangladesh	6
CA - Canada	6
EG - Egitto	6
IQ - Iraq	6
TR - Turchia	6
MX - Messico	5
PK - Pakistan	5
RU - Federazione Russa	5
PH - Filippine	4
CL - Cile	3
EC - Ecuador	3
ES - Italia	3
IR - Iran	3
KR - Corea	3
MY - Malesia	3
PL - Polonia	3
LT - Lituania	2
RS - Serbia	2
SA - Arabia Saudita	2
SI - Slovenia	2
TW - Taiwan	2
UZ - Uzbekistan	2
AU - Australia	1
BB - Barbados	1
BO - Bolivia	1
BS - Bahamas	1
CR - Costa Rica	1
DO - Repubblica Dominicana	1
ET - Etiopia	1
ID - Indonesia	1
JM - Giamaica	1
JO - Giordania	1
LB - Libano	1
LV - Lettonia	1
NI - Nicaragua	1
PA - Panama	1
PE - Perù	1
PT - Portogallo	1
RO - Romania	1
SK - Slovacchia (Repubblica Slovacca)	1
TT - Trinidad e Tobago	1
Totale	16.083

Nome	#
Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation	3.422
Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids	3.037
Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides	3.032
Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases	2.548
New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII	1.733
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions	1.190
Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives	756
Identification and development of new antitumor agents with multi-target action	271
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: Synthesis and biological evaluation for chronic myeloid leukemia treatment	133
Totale	16.122

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	1.045	0	0	0	0	0	0	0	0	0	427	396	222
2021/2022	1.376	185	105	54	95	148	88	70	54	126	160	140	151
2022/2023	1.889	134	265	267	183	159	234	88	131	130	85	140	73
2023/2024	1.480	95	44	51	80	140	295	169	161	107	91	106	141
2024/2025	2.913	767	875	255	347	130	213	159	25	45	29	23	45
2025/2026	783	85	34	90	83	81	55	110	81	66	98	0	0
Totale													16.122

UNICA IRIS Institutional Research Information System